NORAM.OL(NORAM.OL)
NORAM.OL
No analyst ratings available
No analyst price targets available for NORAM.OL
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $110M | $118M | $122M | $113M |
| Low | $106M | $109M | $121M | $109M |
| High | $114M | $128M | $123M | $118M |
| EBITDA Avg | $26M | $28M | $29M | $27M |
| Low | $25M | $26M | $28M | $26M |
| High | $27M | $30M | $29M | $28M |
| EBIT Avg | $5M | $5M | $5M | $5M |
| Low | $5M | $5M | $5M | $5M |
| High | $5M | $6M | $6M | $5M |
| Net Income Avg | $18M | $24M | $28M | $26M |
| Low | $17M | $24M | $25M | $24M |
| High | $19M | $25M | $29M | $27M |
| EPS Avg | $0.42 | $0.56 | $0.62 | $0.59 |
| Low | $0.40 | $0.56 | $0.57 | $0.56 |
| High | $0.44 | $0.57 | $0.67 | $0.62 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 2 | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $28M | $29M | $28M | $29M | $30M | $30M |
| Low | $28M | $29M | $28M | $29M | $30M | $30M |
| High | $28M | $29M | $28M | $29M | $30M | $30M |
| EBITDA Avg | $7M | $7M | $7M | $7M | $7M | $7M |
| Low | $7M | $7M | $7M | $7M | $7M | $7M |
| High | $7M | $7M | $7M | $7M | $7M | $7M |
| EBIT Avg | $1M | $1M | $1M | $1M | $1M | $1M |
| Low | $1M | $1M | $1M | $1M | $1M | $1M |
| High | $1M | $1M | $1M | $1M | $1M | $1M |
| Net Income Avg | $5M | $6M | $6M | $6M | $6M | $6M |
| Low | $5M | $6M | $6M | $6M | $6M | $6M |
| High | $5M | $6M | $6M | $6M | $6M | $6M |
| EPS Avg | $0.11 | $0.13 | $0.13 | $0.14 | $0.15 | $0.15 |
| Low | $0.11 | $0.13 | $0.13 | $0.14 | $0.15 | $0.15 |
| High | $0.11 | $0.13 | $0.13 | $0.14 | $0.15 | $0.15 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |